BiotechTube
Home/Freya Biosciences/Johan van Hylckama Vlieg
JV

Johan van Hylckama Vlieg

CSO, Co-Founder

Freya Biosciences

Therapeutic Areas

Women's HealthReproductive HealthInfertilityEndometriosisPreterm Birth

Freya Biosciences Pipeline

DrugIndicationPhase
Microbial Immunotherapy for IVFInfertility / Poor IVF Outcomes due to Inflammatory DysbiosisPhase 2
Microbial Immunotherapy for EndometriosisEndometriosis-Associated InfertilityPhase 2
Microbial Immunotherapy for Preterm BirthPrevention of Spontaneous Preterm BirthPhase 2

Leadership Team at Freya Biosciences

CA
Colleen Acosta
CEO, Co-Founder
UB
Ulrich Binné
CBO, Co-Founder
PC
Per Cantor
CMO
CL
Crilles Larsen
CTO
View full Freya Biosciences profile